Home › Funds › Newtyn Management, LLC › INDV
Newtyn Management, LLC position in INDV
INDIVIOR PHARMACEUTICALS INC · Health Care
Newtyn Management, LLC reported holding 1,305,795 shares of INDV (INDIVIOR PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$53.6M, representing 6.69% of its reported portfolio and ranking #3 among its reported holdings. Newtyn Management, LLC has disclosed INDV holdings in 8 of the last 8 reported quarters, going back to Q3 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Newtyn Management, LLC's INDV position evolved
Newtyn Management, LLC first disclosed a stake in INDV in Q3 2024 at 868,105 shares (US$8.5M). The position peaked in Q3 2025 at 4,200,000 shares, worth US$101.3M. Across 8 filings, Newtyn Management, LLC increased the stake 4 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 1,305,795 shares valued at US$53.6M — a reduction of -694,205 shares quarter over quarter.. Notable position changes include a 62% increase in Q4 2024 (shares fell 23% over the following quarter), a 58% increase in Q2 2025 (shares rose 64% over the following quarter), a 61% increase in Q3 2025 (shares rose 49% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2024 | 868.11K | $8.46M | New |
| Q4 2024 | 1.41M | $17.48M | Add |
| Q1 2025 | 1.65M | $15.73M | Add |
| Q2 2025 | 2.61M | $38.43M | Add |
| Q3 2025 | 4.20M | $101.26M | Add |
| Q4 2025 | 2.53M | $90.94M | Reduce |
| Q1 2026 | 2.00M | $60.96M | Reduce |
| Q2 2026 | 1.31M | $53.58M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About INDV and 13F data
INDV (INDIVIOR PHARMACEUTICALS INC) is a Health Care company. 53 other funds we track also report a position in INDV — the largest reported positions include OAKTREE CAPITAL MANAGEMENT LP (US$251.4M), Two Seas Capital LP (US$131.6M), Madison Avenue Partners, LP (US$117.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding INDV
- OAKTREE CAPITAL MANAGEMENT LP 6.13M sh · $251.40M · Q2 2026
- Two Seas Capital LP 3.67M sh · $131.61M · Q3 2026
- Madison Avenue Partners, LP 2.87M sh · $117.94M · Q2 2026
- MANGROVE PARTNERS IM, LLC 2.68M sh · $109.83M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 1.65M sh · $67.65M · Q2 2026
- GENDELL JEFFREY L 1.10M sh · $44.98M · Q2 2026
- Soleus Capital Management, L.P. 1.06M sh · $43.66M · Q2 2026
- Claret Asset Management Corp 685.52K sh · $28.13M · Q2 2026
- Divisadero Street Capital Management, LP 601.86K sh · $24.69M · Q2 2026
- Melqart Asset Management (UK) Ltd 585.66K sh · $24.03M · Q2 2026
- Alta Fundamental Advisers LLC 404.53K sh · $16.60M · Q2 2026
- PFM Health Sciences, LP 401.21K sh · $16.46M · Q2 2026
More on Newtyn Management, LLC
FAQ
How long has Newtyn Management, LLC held INDV?
Newtyn Management, LLC has disclosed INDV holdings in 8 of the last 8 reported quarters, going back to Q3 2024.
What is Newtyn Management, LLC's current position in INDV?
As of Q2 2026, Newtyn Management, LLC holds 1.31M shares of INDV (INDIVIOR PHARMACEUTICALS INC), valued at $53.58M, representing 6.69% of its reported portfolio and ranking #3.
Has Newtyn Management, LLC been buying or selling INDV?
In the latest 13F filing (Q2 2026), Newtyn Management, LLC reduced its position in INDV. The position peaked in Q3 2025 at 4.20M shares.
Which other funds hold INDV?
Other major institutional holders of INDV include OAKTREE CAPITAL MANAGEMENT LP, Two Seas Capital LP, Madison Avenue Partners, LP, among 53 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.